Boxer Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,590,000
| Closed | -$18.4M | – | 25 |
|
|
2024
Q3 | $18.4M | Hold |
1,590,000
| – | – | 0.9% | 29 |
|
|
2024
Q2 | $18.7M | Hold |
1,590,000
| – | – | 0.99% | 28 |
|
|
2024
Q1 | $18.9M | Sell |
1,590,000
-60,000
| -4% | -$712K | 0.93% | 32 |
|
|
2023
Q4 | $20.2M | Hold |
1,650,000
| – | – | 1.01% | 26 |
|
|
2023
Q3 | $15.9M | Hold |
1,650,000
| – | – | 0.85% | 36 |
|
|
2023
Q2 | $14.9M | Hold |
1,650,000
| – | – | 0.69% | 39 |
|
|
2023
Q1 | $13M | Buy |
+1,650,000
| New | +$13M | 0.64% | 41 |
|
|
2020
Q1 | – | Sell |
-200,000
| Closed | -$3.56M | – | 64 |
|
|
2019
Q4 | $3.56M | Hold |
200,000
| – | – | 0.2% | 46 |
|
|
2019
Q3 | $2.32M | Hold |
200,000
| – | – | 0.17% | 45 |
|
|
2019
Q2 | $4.43M | Hold |
200,000
| – | – | 0.38% | 31 |
|
|
2019
Q1 | $5.72M | Hold |
200,000
| – | – | 0.66% | 21 |
|
|
2018
Q4 | $3.95M | Hold |
200,000
| – | – | 0.49% | 20 |
|
|
2018
Q3 | $4.42M | Buy |
+200,000
| New | +$4.42M | 0.49% | 18 |
|